These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5491146)

  • 1. [Clinical-pharmacological studies with a new beta receptor blocking substance (LB 46, Visken)].
    Judmaier G; Dienstl F; Schwingshackl H; Amor H
    Wien Klin Wochenschr; 1970 Dec; 82(50):891-3. PubMed ID: 5491146
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical studies with a new beta receptor blocking agent from the indole series (LB 46)].
    Sterz H
    Wien Klin Wochenschr; 1970 Dec; 82(50):894-9. PubMed ID: 4099292
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.
    Giudicelli JF; Schmitt H; Boissier JR
    J Pharmacol Exp Ther; 1969 Jul; 168(1):116-26. PubMed ID: 5792677
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative studies with the beta-receptor blockaders LB 46 and propranolol in healthy persons using the isoproterenol test].
    Bender F; Dotterweich K
    Med Welt; 1971 Sep; 22(37):1444-6. PubMed ID: 4398359
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of cardiac beta-receptors. Studies by means of dose-effect-curves of isoprenaline, propranolol and KL 255].
    Holtermann W; Lochner W
    Arzneimittelforschung; 1970 Jan; 20(1):8-12. PubMed ID: 4392501
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of intravenous pindolol and propranolol in normal man.
    Hicks DC; Arbab AG; Turner P; Hills M
    J Clin Pharmacol New Drugs; 1972; 12(5):212-6. PubMed ID: 4402370
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of sympatheticotonic false regulations with Visken].
    Rosenkranz KA
    Munch Med Wochenschr; 1972 Jun; 114(24):1154-8. PubMed ID: 4403266
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of beta-receptor blocking drugs on the heart rate during submaximal exercise.
    Floor-Wieringa A; Van Strik R; Kesteloot H; Sluyts R
    Eur J Pharmacol; 1970; 10(3):303-10. PubMed ID: 4393072
    [No Abstract]   [Full Text] [Related]  

  • 10. Potency and time effect relationship in man of propranolol and H 56-28. I. Comparative studies after intravenous administration. II. Studies on the ratio of equipotent oral and intravenous doses.
    Johnsson G; Norrby A; Sölvell L
    Acta Pharmacol Toxicol (Copenh); 1967; 25():95-105. PubMed ID: 6072576
    [No Abstract]   [Full Text] [Related]  

  • 11. [Decrease in ventricular frequency in auricular fibrillation using Visken].
    Bender F; Dürholz HH; Gradaus D; Schmidt E
    Med Welt; 1971 Feb; 9():340-1. PubMed ID: 4396541
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pindolol. New beta blocking agent. Effect on cardiac chronotropism and ionotropism and comparison of its activity with propranolol].
    Aquaro G; Baduini G; Pavia M; Poletti T
    Minerva Cardioangiol; 1972 Jun; 20(6):324-9. PubMed ID: 4402731
    [No Abstract]   [Full Text] [Related]  

  • 13. Relative potency of intravenous prinodolol and propranolol in man.
    Arbab AG; Hicks DC; Turner P
    Br J Pharmacol; 1971 Aug; 42(4):665P-666P. PubMed ID: 4940273
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinicopharmacological studies with pindolol following intravenous and oral administration].
    Aellig WH
    Adv Clin Pharmacol; 1976; 11():9-13. PubMed ID: 1032575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies and experiences with beta-adrenergic blocking agents in the treatment of sinus tachycardia in children].
    Diekmann L
    Arztl Forsch; 1970 Jan; 24(1):13-8. PubMed ID: 4398686
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies with LB 46, a new beta-receptor blocking drug.
    Lubawski I; Wale J
    Eur J Pharmacol; 1969; 6(3):345-8. PubMed ID: 5816392
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemodynamic studies with isoprenaline and beta adrenergic receptor blockaders in children with tetralogy of Fallot].
    Diekmann L; Hilgenberg F
    Z Kreislaufforsch; 1972 Jan; 61(1):40-52. PubMed ID: 4554869
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the mechanogram and other circulatory parameters induced by isoprenaline and adrenaline under the effect of verapamil, quinidine and adrenergic substances].
    Haas H
    Arzneimittelforschung; 1970 Apr; 20(4):501-9. PubMed ID: 5467814
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of graded doses of practolol on the tachycardia induced by isoprenaline, Valsalva's manoeuvre and exercise.
    Aellig WH; Prichard BN
    Br J Pharmacol; 1970 May; 39(1):193P-194P. PubMed ID: 4392962
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.
    Ablad B; Brogård M; Ek L
    Acta Pharmacol Toxicol (Copenh); 1967; 25():9-40. PubMed ID: 6072577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.